Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled phase 2 trial
Authors
Haitao Yang (ORCID: https://orcid.org/0000-0002-1875-3268)
Xuefen Huai
Yu Xia
Jiarong Wang
Hongxing Pan (ORCID: https://orcid.org/0000-0002-3791-1241)
Gan Zhao (ORCID: https://orcid.org/0000-0002-8043-6036)
Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled phase 2 trial
Haitao Yang, Xuefen Huai, Yu Xia, Jiarong Wang et al.
Journal
BMC Infectious Diseases
Topics
SARS-CoV-2 and COVID-19 Research
article
Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled phase 2 trial
Haitao Yang, Xuefen Huai, Yu Xia, Jiarong Wang, Hongxing Pan, Gan Zhao, Siyue Jia, Aihua Yao, Bin Wang, Zhijian Wang, Ming Xu, Xin Cheng, Jianfang Xu, Jingxin Li, Danjing Leng
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC Infectious DiseasesVol. 25(1)
Institutions
Xinjiang Uygur Autonomous Region Disease Prevention and Control Center (CN), Jiangsu Provincial Center for Disease Control and Prevention (CN), ARTS Group (China) (CN), Southeast University (CN)